Dashboard
Manage Tickers

DNLI


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-denali-therapeutics-maintains-35-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:36:20

Cantor Fitzgerald analyst Charles Duncan reiterates Denali Therapeutics (NASDAQ:DNLI) with a Overweight and maintains $35 pr...

hc-wainwright--co-reiterates-buy-on-denali-therapeutics-maintains-90-price-target
HC Wainwright & Co. Reiterates Buy on Dena...
09/04/2024 11:37:53

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $90 price ...

b-of-a-securities-maintains-buy-on-denali-therapeutics-raises-price-target-to-29
B of A Securities Maintains Buy on Denali ...
09/04/2024 11:37:24

B of A Securities analyst Tazeen Ahmad maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and raises the price target fr...

denali-therapeutics-announces-outcome-of-recent-fda-meeting-plans-to-file-for-accelerated-approval-of-tividenofusp-alfa-in-treatment-of-hunter-syndrome
Denali Therapeutics Announces Outcome Of R...
09/03/2024 12:28:34

hc-wainwright--co-reiterates-buy-on-denali-therapeutics-maintains-90-price-target
HC Wainwright & Co. Reiterates Buy on Dena...
08/15/2024 10:44:29

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $90 price ...

denali-therapeutics-announces-publication-in-science-translational-medicine-demonstrating-the-potential-of-the-otv-platform-to-achieve-broad-biodistribution-of-antisense-oligonucleotides-in-the-cns-and-skeletal-and-cardiac-muscle-following-iv-administration
Denali Therapeutics Announces Publication ...
08/14/2024 18:02:03

Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineer...

hc-wainwright--co-maintains-buy-on-denali-therapeutics-lowers-price-target-to-90
HC Wainwright & Co. Maintains Buy on Denal...
08/05/2024 19:31:07

HC Wainwright & Co. analyst Andrew Fein maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price targ...

citigroup-maintains-buy-on-denali-therapeutics-raises-price-target-to-32
Citigroup Maintains Buy on Denali Therapeu...
08/02/2024 16:17:47

Citigroup analyst David Hoang maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and raises the price target from $26 to...

wedbush-maintains-outperform-on-denali-therapeutics-lowers-price-target-to-26
Wedbush Maintains Outperform on Denali The...
08/02/2024 13:53:23

Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $...

denali-therapeutics-q2-2024-gaap-eps-059-beats-068-estimate-cash-balance-of-approximately-135b
Denali Therapeutics Q2 2024 GAAP EPS $(0.5...
08/01/2024 11:25:44

jp-morgan-maintains-overweight-on-denali-therapeutics-raises-price-target-to-29
JP Morgan Maintains Overweight on Denali T...
07/10/2024 16:26:36

JP Morgan analyst Jessica Fye maintains Denali Therapeutics (NASDAQ:DNLI) with a Overweight and raises the price target from...

Core News & Articles
'Biogen Is Pursuing More Dealmaking This Y...
06/27/2024 15:39:59

https://endpts.com/biogen-is-pursuing-more-dealmaking-this-year-with-plans-to-spend-up-to-8B/  

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday
Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

denali-therapeutics-says-fda-has-selected-dnl126-for-participation-in-support-for-clinical-trials-advancing-rare-disease-therapeutics-pilot-program
Denali Therapeutics Says FDA Has Selected ...
06/03/2024 12:09:50

DNL126 is an investigational enzyme replacement therapy designed to cross the BBB for the potential treatment of MPS IIIA (Sanf...

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday
Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

wedbush-maintains-outperform-on-denali-therapeutics-lowers-price-target-to-30
Wedbush Maintains Outperform on Denali The...
05/08/2024 14:20:54

Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $...

stifel-maintains-hold-on-denali-therapeutics-lowers-price-target-to-22
Stifel Maintains Hold on Denali Therapeuti...
05/08/2024 13:19:11

Stifel analyst Paul Mattels maintains Denali Therapeutics (NASDAQ:DNLI) with a Hold and lowers the price target from $26 to ...

hc-wainwright--co-reiterates-buy-on-denali-therapeutics-maintains-95-price-target
HC Wainwright & Co. Reiterates Buy on Dena...
05/08/2024 13:11:18

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $95 price ...

denali-therapeutics-q1-eps-068-beats-070-estimate
Denali Therapeutics Q1 EPS $(0.68) Beats $...
05/07/2024 20:50:23

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $...

denali-therapeutics-completes-enrollment-for-regimen-g-evaluating-eif2b-agonist-dnl343-in-phase-23-healey-als-platform-trial
Denali Therapeutics Completes Enrollment f...
05/01/2024 12:11:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION